AstraZeneca Hit Again With Antitrust Charges

Law360, New York (March 1, 2006, 12:00 AM EST) -- A government service cooperative has charged AstraZeneca with violating U.S. competition law, the latest swipe in a string of suits filed by nearly a dozen unions, pension funds and government agencies accusing the pharmaceutical giant of illegally trying to prevent generic versions of its blockbuster heart drug, Toprol-XL, from entering the marketplace.

The National Joint Powers Association, a self-funded cooperative which supplies goods and services to government agencies, says that Anglo-Swedish AstraZeneca’s illegal monopolization and attempt to monopolize the market for Toprol-XL and its generic versions...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.